Coronavirus surveillance testing for population-level occurrence
For universities, businesses, and communities eager to reconnect and resume everyday activities, surveillance testing of the SARS-CoV-2 virus is essential to helping monitor population level occurrence.
Our PCR testing research solution enables comprehensive, high-frequency surveillance testing at a scale to support your entire community.
Questions you may have about implementing a surveillance testing program
- Should we develop a testing program with vaccines on the horizon?
- Is it easy to deploy?
- How often will we need to test our population?
- Can we trust the data?
- How much will it cost?
Answers to your questions
Even with vaccines on the horizon, it is important to develop a surveillance testing program for your population.
Are you a scientist?
The Applied Biosystems TaqCheck SARS-CoV-2 Fast PCR Assay combines the quality results you expect from gold-standard PCR technology with rapid answers to help you drive decisions to keep your community safe.
Fast—each high-throughput kit provides 1,200 direct-to-PCR reactions
Cost effective—helps reduce infrastructure, supply, reagent, and personnel costs across the entire workflow
Easy to use—simplified, gold-standard PCR workflow from raw saliva; leverages cutting-edge Applied Biosystems QuantStudio Design & Analysis software
Multi-target design—compensates for emerging SARS-CoV-2 variants and mutations to provide confidence in results
Find out how the TaqCheck SARS-CoV-2 Fast PCR Assay can help enable your lab to provide maximum surveillance testing research support.
It will take time for enough people to be vaccinated to reach a threshold sufficient to slow the spread of the virus. It is critical to continue to maintain surveillance for SARS-CoV-2 at a community or population level to identify the incidence and prevalence of the occurrence. This data analysis is essential to planning, implementing, and maintaining practices to keep people safe.
Implementing a surveillance testing plan is easier than you may think
Figure 1. Streamlined sample workflow enables quick collection to results
The TaqCheck SARS-CoV-2 Fast PCR Assay makes it easy to process samples. Using raw saliva samples, the test is easy to use and requires no special devices or techniques. Each kit can test up to 1,200 samples using a format that makes it simple for a lab to process and analyze data quickly.
Test frequently and often
The frequency with which you test depends on many factors, including test positivity rate, the size of the community, your community’s tolerance for disease outbreak, operational capabilities, and budget. CDC recommendations (1) and analytical modeling studies (2,3) provide further information that may help you develop a strategy that works best for your community.
Gold-standard PCR testing offers trusted results
The TaqCheck SARS-CoV-2 Fast PCR Assay uses trusted PCR (polymerase chain reaction) technology, a scientific methodology that can detect the genetic information of the novel coronavirus, even at low levels. Simply no other type of testing methodology that can provide answers as definitively as PCR.
Coronavirus testing with the TaqCheck SARS-CoV-2 Fast PCR Assay is affordable
Because the TaqCheck SARS-CoV-2 Fast PCR Assay is easy to use and scalable, it costs significantly less than other methods. By eliminating the need for expensive collection devices and extraction instruments, and minimizing staffing requirements and use of supplies and safety equipment, TaqCheck testing offers a lower total price per sample than other methods.
A superior surveillance testing research solution to meet
your testing needs
Easy, fast, and affordable, the Applied Biosystems TaqCheck SARS-CoV-2 Fast PCR Assay leverages gold-standard PCR technology and offers fast results, enabling you to meet the urgent demands of today’s surveillance testing challenges, so you can get the answers you need to keep moving.
Built on a foundation of research at the University of Illinois at Urbana-Champaign, SHIELD Campaign
Direct saliva testing can address bottlenecks of time, cost and supplies. The University of Illinois at Urbana-Champaign developed a test that enables fast and frequent testing on a large scale. University of Illinois researchers also conducted initial verification work for TaqCheck.
Example surveillance testing research challenge
Consider a university looking to perform surveillance testing for a population of 25,000 undergraduates weekly. That’s 5,000 tests each day—and a really long line. The TaqCheck kit allows the processing of over 350 samples at once, significantly ramping up your ability to get answers to help protect your campus community.
1. Testing, Screening, and Outbreak Response for Institutions of Higher Education (IHEs). Centers for Disease Control and Prevention, 21 Oct 2020. www.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/ihe-testing.html
2. Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States. Paltiel et al. JAMA Network Open. 2020;3(7):e2016818. doi:10.1001/jamanetworkopen.2020.16818
3. Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance. Larremore, et al. MedRxiv Preprint. 08 Sep. 2020 Sep 8. doi: 10.1101/2020.06.22.20136309
For Research Use Only. Not for use in diagnostic procedures.